Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols.
about
Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines.Dendritic cell fusion vaccines for cancer immunotherapy.T cell-mediated immunotherapy of metastases: state of the art in 2005.Single-cell RNA-seq reveals activation of unique gene groups as a consequence of stem cell-parenchymal cell fusion.Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.Cell fusion: from hybridoma to dendritic cell-based vaccine.Purified dendritic cell-tumor fusion hybrids supplemented with non-adherent dendritic cells fraction are superior activators of antitumor immunity.Regulation of tumor immunity by tumor/dendritic cell fusionsVarious ways to improve whole cancer cell vaccines.Tumor ablation by intratumoral Ra-224-loaded wires induces anti-tumor immunity against experimental metastatic tumors.Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine.Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells.Dendritic cells based immunotherapy.In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.A Novel Heat Shock Protein 70-based Vaccine Prepared from DC-Tumor Fusion Cells.
P2860
Q34898366-0B719891-6F0A-445A-BAC5-FF700F4F621AQ36150517-213DCD84-CFFC-417D-A2A4-C6EAE2213097Q36210864-3764BE28-7DD4-4055-85D2-FAD315E2BA07Q36708133-33850A1C-8DC2-4E60-8730-F54F51D55080Q36908547-701A7428-DD24-463B-B315-E8E5053474B2Q37259630-7095E109-6C67-4565-A998-25973FA3AA61Q37510538-DBC3EF8C-C2FB-47BD-8473-F3875F7CE2B8Q37806963-8D14CB97-50C8-4825-8CD9-62E8098E8AFDQ38206582-8CEC0B42-6F00-4A27-82A3-519B54D5C584Q38946861-EA6031ED-7221-4121-AC12-AF3DF1854843Q40559621-A19FC94E-BCFC-455E-96C8-1ECC3A3EFAC5Q42726581-489E8815-2D9F-4C79-8791-3FC6BD8E5D24Q43043935-BC0A9046-6D25-4E41-949D-E0005205828BQ44272941-B86CC551-632A-492D-8AAC-D16ABCC98825Q47362481-23E35DD4-01AD-4194-B0BC-DA0CCA9956CC
P2860
Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Tumour cell-dendritic cell fus ...... rsus electro-fusion protocols.
@en
type
label
Tumour cell-dendritic cell fus ...... rsus electro-fusion protocols.
@en
prefLabel
Tumour cell-dendritic cell fus ...... rsus electro-fusion protocols.
@en
P2860
P1476
Tumour cell-dendritic cell fus ...... rsus electro-fusion protocols.
@en
P2093
Matthias Lindner
V Schirrmacher
P2860
P304
P356
10.1046/J.1365-2362.2002.00968.X
P577
2002-03-01T00:00:00Z